Transporters in human platelets: Physiologic function and impact for pharmacotherapy

Blood

Volumn 119, Issue 15, 2012, Pages 3394-3402

  Jedlitschky, Gabriele ^a   Greinacher, Andreas ^a,b   Kroemer, Heyo K ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b UNIVERSITY MEDICINE GREIFSWALD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ACETYLSALICYLIC ACID; ATORVASTATIN; DIPYRIDAMOLE; ETOPOSIDE; EXCITATORY AMINO ACID TRANSPORTER 3; GLUTATHIONE; IBUPROFEN; INDOMETACIN; LEUKOTRIENE C4; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 3; MULTIDRUG RESISTANCE PROTEIN 4; NITRIC OXIDE; PRASTERONE SULFATE; PROSTAGLANDIN E2; RESERPINE; ROSUVASTATIN; SEROTONIN TRANSPORTER; TETRABENAZINE; THROMBOXANE A2; VERLUKAST; VESICULAR MONOAMINE TRANSPORTER 2;

ACUTE CORONARY SYNDROME; BINDING AFFINITY; BLOOD CLOTTING; CELL GRANULE; CELL MEMBRANE; CELLULAR DISTRIBUTION; ENDOPLASMIC RETICULUM; ENDOTHELIUM CELL; EXOCYTOSIS; EXTRACELLULAR MATRIX; HEMATOPOIETIC STEM CELL; HUMAN; MEGAKARYOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; REVIEW; SECRETORY VESICLE; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE FUNCTION; THROMBOGENESIS;

EID: 84859849886     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-09-336933     Document Type: Review

References (100)

1. Leslie M. Cell biology. Beyond clotting: the powers of platelets. Science. 2010;328(5978):562-564.
2. Krauel K, Pötschke C, Weber C, et al. Platelet factor 4 binds to bacteria, inducing antibodies cross-reacting with the major antigen in heparin-induced thrombocytopenia. Blood. 2011;117(4): 1370-1378.
3. White JG. Anatomy and structural organization of the platelet. In: Colman RW, Hirsch J, Marder VJ, Salzman EW, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice (3rd Ed). Philadelphia, PA: Lippincott; 1994:397-413.
4. Youssefian T, Cramer EM. Megakaryocyte dense granule components are sorted in multivesicular bodies. Blood. 2000;95(12):4004-4007. (Pubitemid 30412881)
5. Youssefian T, Masse JM, Rendu F, Guichard J, Cramer EM. Platelet and megakaryocyte dense granules contain glycoproteins Ib and IIb-IIIa. Blood. 1997;89(11):4047-4057. (Pubitemid 27220950)
6. Cattaneo M. Inherited, platelet-based bleeding disorders. J Thromb Haemost. 2003;12(7):1628-1636.
7. Hermansky F, Pudlak P. Albinism associated with hemorrhagic diathesis and unusual pigmented reticular cells in the bone marrow. Blood. 1959; 14(2):162-169.
8. Huizing M, Gahl WA. Disorders of vesicles of lysosomal lineage: the Hermansky-Pudlak syndromes. Curr Mol Med. 2002;2(5):451-467. (Pubitemid 34760028)
9. .Wei ML. Hermansky-Pudlak syndrome: a disease of protein trafficking and organelle function. Pigment Cell Res. 2006;19(1):19-42.
10. Jedlitschky G, Tirschmann K, Lubenow LE, et al. The nucleotide transporter MRP4 (ABCC4) is highly expressed in human platelets and present in dense granules, indicating a role in mediator storage. Blood. 2004;104(12):3603-3610. (Pubitemid 39564434)
11. Deeley RG, Westlake C, Cole SP. Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins. Physiol Rev. 2006;86(3):849-899. (Pubitemid 44033384)
12. Russel FG, Koenderink JB, Masereeuw R. Multidrug resistance protein 4 (MRP4/ABCC4): a versatile efflux transporter for drugs and signalling molecules. Trends Pharmacol Sci. 2008;29(4): 200-207.
13. Jedlitschky G, Cattaneo M, Lubenow LE, et al. Role of MRP4 (ABCC4) in platelet adenine nucleotide-storage: evidence from patients with deltastorage pool deficiencies. Am J Pathol. 2010; 176(3):1097-1103.
14. Mattiello T, Guerriero R, Lotti LV, et al. Aspirin extrusion from human platelets through multidrug resistance protein-4-mediated transport evidence of a reduced drug action in patients after coronary artery bypass grafting. J Am Coll Cardiol. 2011; 58(7):752-761.
15. Rius M, Hummel-Eisenbeiss J, Keppler DJ. ATP-dependent transport of leukotrienes B4 and C4 by the multidrug resistance protein ABCC4 (MRP4). Pharmacol Exp Ther. 2008;324(1):86-94. (Pubitemid 350294174)
16. Ulrych T, Böhm A, Polzin A, et al. Release of sphingosine-1- phosphate from human platelets is dependent on thromboxane formation. J Thromb Haemost. 2011;9(4):790-798.
17. Maurer-Spurej E, Pittendreigh C, Solomons K. The influence of selective serotonin reuptake inhibitors on human platelet serotonin. Thromb Haemost. 2004;91(1):119-128. (Pubitemid 38120206)
18. Owens MJ, Nemeroff CB. Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clin Chem. 1994;40(2):288-295. (Pubitemid 24072594)
19. Rainesalo S, Keränen T, Saransaari P, Honkaniemi J. GABA and glutamate transporters are expressed in human platelets. Brain Res Mol Brain Res. 2005;141(2):161-165. (Pubitemid 41608697)
20. Reed GL, Fitzgerald ML, Polgar J. Molecular mechanisms of platelet exocytosis: insights into the "secrete" life of thrombocytes. Blood. 2000; 96(10):3334-3342.
21. Niessen J, Jedlitschky G, Grube M, et al. Human platelets express organic anion-transporting peptide 2B1, an uptake transporter for atorvastatin. Drug Metab Dispos. 2009;37(5):1129-1137.
22. Borst P, Elferink RO. Mammalian ABC transporters in health and disease. Annu Rev Biochem. 2002;71:537-592. (Pubitemid 34800230)
23. Vasiliou V, Vasiliou K, Nebert DW. Human ATP-binding cassette (ABC) transporter family. Hum Genomics. 2009;3(3):281-290.
24. He L, Vasiliou K, Nebert DW. Analysis and update of the human solute carrier (SLC) gene superfamily. Hum Genomics. 2009;3(2):195-206.
25. Hediger MA, Romero MF, Peng JB, Rolfs A, Takanaga H, Bruford EA. The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteins. Pflugers Arch. 2004;447(5):465-468. (Pubitemid 38241432)
26. Albrecht C, Viturro E. The ABCA subfamily-gene and protein structures, functions and associated hereditary diseases. Pflugers Arch. 2007;453(5): 581-589. (Pubitemid 46192531)
27. Greinacher A, Wesche J, Hammer E, et al. Characterization of the human neutrophil alloantigen- 3a. Nat Med. 2010;16(1):45-48.
28. Wesche J, Jehmlich U, Schwertz H, et al. Expression of the choline transporter like protein 2 (CTL2) in platelets. Hämostaseologie. 2011;A78. www.haemostaseologie-online.com. Accessed September 16, 2011.
29. Niessen J, Jedlitschky G, Grube M, et al. Expression of ABC-type transport proteins in human platelets. Pharmacogenet Genomics. 2010;20(6): 396-400.
30. Reid G, Wielinga P, Zelcer N, et al. The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs. Proc Natl Acad Sci U S A. 2003;100(16):9244-9249. (Pubitemid 37033914)
31. Gradhand U, Lang T, Schaeffeler E, et al. Variability in human hepatic MRP4 expression: influence of cholestasis and genotype. Pharmacogenomics J. 2007;8(1):42-52.
32. Callan MB, Bennett JS, Phillips DK, et al. Inherited platelet delta-storage pool disease in dogs causing severe bleeding: an animal model for a specific ADP deficiency. Thromb Haemost. 1995; 74(3):949-953.
33. Eikelboom JW, Hankey GJ. Overexpression of the multidrug resistance protein-4 transporter in patients undergoing coronary artery bypass graft surgery a cause of aspirin resistance? J Am Coll Cardiol. 2011;58(7):762-764.
34. Hankey GJ, Eikelboom JW. Aspirin resistance. Lancet. 2006;367(9510):606- 617. (Pubitemid 43250663)
35. Lam BK, Owen WF Jr, Austen KF, Soberman RJ. The identification of a distinct export step following the biosynthesis of leukotriene C4 by human eosinophils. J Biol Chem. 1989;264(22):12885-12889. (Pubitemid 19194859)
36. Schaub T, Ishikawa T, Keppler D. ATP-dependent leukotriene export from mastocytoma cells. FEBS Lett. 1991;279(1):83-86.
37. Leier I, Jedlitschky G, Buchholz U, Cole SP, Deeley RG, Keppler D. The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. J Biol Chem. 1994;269(45):27807-27810. (Pubitemid 24354499)
38. Wijnholds J, Evers R, van Leusden MR, et al. Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein. Nat Med. 1997;3(11):1275-1279. (Pubitemid 27508831)
39. Hirohashi T, Suzuki H, Sugiyama Y. Characterization of the transport properties of cloned rat multidrug resistance-associated protein 3 (MRP3). J Biol Chem. 1999;274(21):15181-15185.
40. 4 synthase in platelets and species distribution of the enzyme activity. Eur J Biochem. 1998;251(1):227-235.
41. Rius M, Thon WF, Keppler D, Nies AT. Prostanoid transport by multidrug resistance protein 4 (mrp4/abcc4) localized in tissues of the human urogenital tract. J Urol. 2005;174(6):2409-2414. (Pubitemid 41611839)
42. Rivera R, Chun J. Biological effects of lysophospholipids. Rev Physiol Biochem Pharmacol. 2008;160:25-46.
43. Mitra P, Oskeritzian CA, Payne SG, Beaven MA, Milstien S, Spiegel S. Role of ABCC1 in export of sphingosine-1-phosphate from mast cells. Proc Natl Acad Sci U S A. 2006;103(44):16394-16399. (Pubitemid 44715207)
44. Chen ZS, Lee K, Kruh GD. Transport of cyclic nucleotides and estradiol 17-beta-D-glucuronide by multidrug resistance protein 4: resistance to 6-mercaptopurine and 6-thioguanine. J Biol Chem. 2001;276(36):33747-33754.
45. Daniel J, Ashby B, Pulcinelli F. Platelet signaling: cAMP and cGMP. In: Gresele P, Page C, Fuster V, Vermylen J, eds. Platelets in Thrombotic and Non-Thrombotic Disorders. Cambridge, United Kingdom: Cambridge University Press; 2002:290-304.
46. Gresele P, Momi S, Falcinelli E. Antiplatelet therapy: phosphodiesterase inhibitors. Br J Clin Pharmacol. 2011;72(4):634-646.
47. Gieger C, Radhakrishnan A, Cvejic A, et al. New gene functions in megakaryopoiesis and platelet formation. Nature. 2011;480(7376):201-208.
48. Kruh GD, Belinsky MG, Gallo JM, Lee K. Physiological and pharmacological functions of Mrp2, Mrp3 and Mrp4 as determined from recent studies on gene disrupted mice. Cancer Metastasis Rev. 2007;26(1):5-14. (Pubitemid 46452179)
49. Sjölinder M, Tornhamre S, Claesson HE, Hydman J, Lindgren J. Characterization of a leukotriene C4 export mechanism in human platelets: possible involvement of multidrug resistance-associated protein 1. J Lipid Res. 1999;40(3): 439-446. (Pubitemid 29116147)
50. Rius M, Nies AT, Hummel-Eisenbeiss J, Jedlitschky G, Keppler D. Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membrane. Hepatology. 2003;38(2):374-384. (Pubitemid 36919858)
51. Leier I, Jedlitschky G, Buchholz U, et al. ATP-dependent glutathione disulphide transport mediated by the MRP gene-encoded conjugate export pump. Biochem J. 1996;314(2):433-437. (Pubitemid 26075650)
52. Sasaki M, Shoji A, Kubo Y, Nada S, Yamaguchi A. Cloning of rat ABCA7 and its preferential expression in platelets. Biochem Biophys Res Commun. 2003;304(4):777-782. (Pubitemid 36513556)
53. Daleke DL. Regulation of transbilayer plasma membrane phospholipid asymmetry. J Lipid Res. 2003;44(2):233-242. (Pubitemid 37303867)
54. Handin RI. Inherited platelet disorders. Hematology. 2005;2005(1):396- 402.
55. Morel O, Morel N, Freyssinet JM, Toti F. Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses. Platelets. 2008;19(1):9-23. (Pubitemid 351171554)
56. Zwaal RF, Comfurius P, Bevers EM. Scott syndrome, a bleeding disorder caused by defective scrambling of membrane phospholipids. Biochim Biophys Acta. 2004;1636(2):119-128. (Pubitemid 38780788)
57. Stormorken H, Holmsen H, Sund R, et al. Studies on the haemostatic defect in a complicated syndrome: an inverse Scott syndrome platelet membrane abnormality? Thromb Haemost. 1995; 74(5):1244-1251.
58. Zhou Q, Zhao J, Stout JG, Luhm RA, Wiedmer T, Sims PJ. Molecular cloning of human plasma membrane phospholipid scramblase: a protein mediating transbilayer movement of plasma membrane phospholipids. J Biol Chem. 1997; 272(29):18240-18244.
59. Bodzioch E, Orso J, Klucken T, et al. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet. 1999; 22(4):347-351.
60. Rust S, Rosier M, Funke H, et al. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet. 1999;22(4):352-355. (Pubitemid 29369525)
61. Hamon Y, Broccardo C, Chambenoit O, et al. ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine. Nat Cell Biol. 2000;2(7):399-406.
62. Albrecht C, McVey JH, Elliott JI, et al. A novel missense mutation in ABCA1 results in altered protein trafficking and reduced phosphatidylserine translocation in a patient with Scott syndrome. Blood. 2005;106(2):542-549. (Pubitemid 40981249)
63. Tanaka N, Abe-Dohmae S, Iwamoto N, Yokoyama S. Roles of ATP-binding cassette transporter A7 in cholesterol homeostasis and host defense system. J Atheroscler Thromb. 2011;18(4):274-281.
64. Hollingworth P, Harold D, Sims R, et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet. 2011;43(5):429-435.
65. Smit JJ, Schinkel AH, Mol CA, et al. Tissue distribution of the human MDR3 P-glycoprotein. Lab Invest. 1994;71(5):638-649. (Pubitemid 24374570)
66. Oude Elferink RP, Paulusma CC. Function and pathophysiological importance of ABCB4 (MDR3 P-glycoprotein). Pflugers Arch. 2007;453(5):601-610. (Pubitemid 46192533)
67. Choi JW, Herr DR, Noguchi K, et al. LPA receptors: subtypes and biological actions. Annu Rev Pharmacol Toxicol. 2010;50:157-186.
68. Siess W, Zangl KJ, Essler M, et al. Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions. Proc Natl Acad Sci U S A. 1999;96(12):6931-6936. (Pubitemid 29274987)
69. Pamuklar Z, Lee JS, Cheng HY, et al. Individual heterogeneity in platelet response to lysophosphatidic acid: evidence for a novel inhibitory pathway. Arterioscler Thromb Vasc Biol. 2008;28(3): 555-561.
70. Srikiatkhachorn A, Suwattanasophon C, Ruangpattanatawee U, Phansuwan-Pujito P. 2002-Wolff Award. 5-HT2A receptor activation and nitric oxide synthesis: a possible mechanism determining migraine attacks. Headache. 2002;42(7):566-574.
71. Dees C, Akhmetshina A, Zerr P, et al. Plateletderived serotonin links vascular disease and tissue fibrosis. J Exp Med. 2011;208(5):961-972.
72. Ramamoorthy S, Bauman AL, Moore KR, et al. Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proc Natl Acad Sci U S A. 1993;90(6):2542-2546. (Pubitemid 23078664)
73. Lesch KP, Wolozin BL, Estler HC, Murphy DL, Riederer P. Isolation of a cDNA encoding the human brain serotonin transporter. J Neural Transm Gen Sect. 1993;91(1):67-72. (Pubitemid 23075433)
74. Lesch KP, Wolozin BL, Murphy DL, Reiderer P. Primary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporter. J Neurochem. 1993;60(6):2319-2322. (Pubitemid 23148809)
75. Chen NH, Reith ME, Quick MW. Synaptic uptake and beyond: the sodium- and chloride-dependent neurotransmitter transporter family SLC6. Pflugers Arch. 2004;447(5):519-531. (Pubitemid 38241438)
76. Rudnick G, Clark J. From synapse to vesicle: the reuptake and storage of biogenic amine neurotransmitters. Biochim Biophys Acta. 1993; 1144(3):249-263. (Pubitemid 23290252)
77. Bakish D, Cavazzoni P, Chudzik J, Ravindran A, Hrdina PD. Effects of selective serotonin reuptake inhibitors on platelet serotonin parameters in major depressive disorder. Biol Psychiatry. 1997;41(2):184-190. (Pubitemid 27062658)
78. Neuger J, Wistedt B, Sinner B, Aberg-Wistedt A, Stain-Malmgren R. The effect of citalopram treatment on platelet serotonin function in panic disorders. Int Clin Psychopharmacol. 2000;15(2):83-91. (Pubitemid 30142800)
79. Maurer-Spurej E. Serotonin reuptake inhibitors and cardiovascular diseases: a platelet connection. Cell Mol Life Sci. 2005;62(2):159-170. (Pubitemid 40193040)
80. Andrade C, Sandarsh S, Chethan KB, Nagesh KS. Serotonin reuptake inhibitor antidepressants and abnormal bleeding: a review for clinicians and a reconsideration of mechanisms. J Clin Psychiatry. 2010;71(12):1565-1575.
81. Greenberg BD, Tolliver TJ, Huang SJ, Li Q, Bengel D, Murphy DL. Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am J Med Genet. 1999;88(1):83-87. (Pubitemid 29075327)
82. Nakatani D, Sato H, Sakata Y, et al. Influence of serotonin transporter gene polymorphism on depressive symptoms and new cardiac events after acute myocardial infarction. Am Heart J. 2005; 150(4):652-658. (Pubitemid 41396493)
83. Sue S, Zhao J, Bremner JD, et al. Serotonin transporter gene, depressive symptoms, and interleukin-6. Circ Cardiovasc Genet. 2009;2(6): 614-620.
84. Bengel D, Murphy DL, Andrews AM, et al. Altered brain serotonin homeostasis and locomotor insensitivity to 3,4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice. Mol Pharmacol. 1998;53(4):649-655. (Pubitemid 28196486)
85. Erickson JD, Eiden LE, Hoffman BJ. Expression cloning of a reserpine-sensitive vesicular monoamine transporter. Proc Natl Acad Sci U S A. 1992;89(22):10993-10997.
86. Erickson JD, Schafer MK, Bonner TI, Eiden LE, Weihe E. Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter. Proc Natl Acad Sci U S A. 1996; 93(10):5166-5171. (Pubitemid 26162890)
87. Nirenberg MJ, Liu Y, Peter D, Edwards RH, Pickel VM. The vesicular monoamine transporter 2 is present in small synaptic vesicles and preferentially localizes to large dense core vesicles in rat solitary tract nuclei. Proc Natl Acad Sci U S A. 1995;92(19):8773-8777.
88. Takanaga H, Mackenzie B, Hediger MA. Sodium-dependent ascorbic acid transporter family SLC23. Pflugers Arch. 2004;447(5):677-682. (Pubitemid 38241453)
89. Savini I, Catani MV, Arnone R, et al. Translational control of the ascorbic acid transporter SVCT2 in human platelets. Free Radic Biol Med. 2007; 42(5):608-616. (Pubitemid 46205144)
90. Chintala S, Tan J, Gautam R, et al. The Slc35d3 gene, encoding an orphan nucleotide sugar transporter, regulates platelet-dense granules. Blood. 2007;109(4):1533-1540. (Pubitemid 46239586)
91. Ishida N, Kawakita M. Molecular physiology and pathology of the nucleotide sugar transporter family (SLC35). Pflugers Arch. 2004;447(5):768-775. (Pubitemid 38241465)
92. Vaughan CJ, Gotto AM Jr, Basson CT. The evolving role of statins in the management of atherosclerosis. J Am Coll Cardiol. 2000;35(1):1-10. (Pubitemid 30061252)
93. Futterman LG, Lemberg L. Statin pleiotropy: fact or fiction? Am J Crit Care. 2004;13(3):244-249. (Pubitemid 39456745)
94. Li H, Lewis A, Brodsky S, Rieger R, Iden C, Goligorsky MS. Homocysteine induces 3-hydroxy-3-methylglutaryl coenzyme A reductase in vascular endothelial cells: a mechanism for development of atherosclerosis? Circulation. 2002; 105(9):1037-1043. (Pubitemid 34212610)
95. Mühlhäuser U, Zolk O, Rau T, Münzel F, Wieland T, Eschenhagen T. Atorvastatin desensitizes beta-adrenergic signalling in cardiac myocytes via reduced isoprenylation of G-protein gamma-subunits. FASEB J. 2006;20(6):785-787. (Pubitemid 46671215)
96. Niemi M, Schaeffeler E, Lang T, et al. High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1). Pharmacogenetics. 2004; 14(7):429-440. (Pubitemid 38971233)
97. Grube M, Köck K, Oswald S, et al. Organic anion transporting polypeptide 2B1 is a high-affinity transporter for atorvastatin and is expressed in the human heart. Clin Pharmacol Ther. 2006; 80(6):607-620. (Pubitemid 44920223)
98. Ho RH, Tirona RG, Leake BF, et al. Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics. Gastroenterology. 2006;130(6):1793-1806.
99. Bednarek-Tupikowska G, Gosk I, Szuba A, et al. Influence of dehydroepiandrosterone on platelet aggregation, superoxide dismutase activity and serum lipid peroxide concentrations in rabbits with induced hypercholesterolemia. Med Sci Monit. 2000;6(1):40-45. (Pubitemid 30158236)
100. Verschoor A, Neuenhahn M, Navarini AA, et al. A platelet-mediated system for shuttling bloodborne bacteria to CD8alpha+ dendritic cells depends on glycoprotein GPIb and complement C3. Nat Immunol. 2011;12(12):1194-1201.